506235 announcements Alembic Ltd. announcements and dividends declared BSE
Alembic Ltd. Complete list of announcements declared & dividend announcements by Alembic Ltd. 506235
Alembic Ltd. 506235 listed on BSE and deals inAnnouncements and dividends declared by Alembic Ltd. 506235
Alembic gets USFDA nod for generic levothyroxine sodium tablets
Alembic Pharmaceuticals has secured final approval from the US health regulator for its generic levothyroxine sodium tablets. This medication is used as a replacement therapy for hypothyroidism. The approval covers multiple strengths of the tablets. This d
Announcement as on 22 May 2026
Alembic Pharma gets USFDA tentative nod for generic prostate cancer drug
Alembic Pharmaceuticals has secured tentative approval from the USFDA for its generic version of Darolutamide tablets, targeting prostate cancer treatment. The approval is for the 300 mg strength. The drug is a generic version of Nubeqa Tablets. The robust
Announcement as on 14 May 2026
Alembic Pharma gets USFDA nod for generic cancer, arthritis injection
Alembic Pharmaceuticals has received final approval from the US Food and Drug Administration for its generic methotrexate injection, used to treat multiple cancers and arthritis conditions. The approval covers key dosage formats and confirms therapeutic eq
Announcement as on 16 April 2026
Alembic Pharma gets USFDA nod for generic drug
Alembic Pharmaceuticals has secured approval from the US health regulator for a generic seizure medication. The company received final clearance from the USFDA for Lamotrigine orally disintegrating tablets. This drug is therapeutically equivalent to GlaxoS
Announcement as on 26 February 2026
Alembic Pharma gets USFDA nod to market generic anti-fungal solution
The company has received final approval from the US Food & Drug Administration (USFDA) for Efinaconazole Topical Solution (10 per cent).
Announcement as on 24 February 2026
Announcements by Alembic Ltd. first page | Next page |
506235 Alembic Ltd. current price & indicator signals
Recent prices of 506235 Alembic Ltd. are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 22 Fri May 2026 | 87.46 | 87.11 to 88.85 | 0.09% | 0.69 times |
| 21 Thu May 2026 | 87.38 | 87.00 to 89.20 | -0.13% | 0.77 times |
| 20 Wed May 2026 | 87.49 | 86.80 to 88.51 | -2.75% | 0.72 times |
| 19 Tue May 2026 | 89.96 | 88.00 to 91.00 | 1.67% | 1.15 times |
| 18 Mon May 2026 | 88.48 | 86.88 to 90.38 | -1.49% | 0.58 times |
| 15 Fri May 2026 | 89.82 | 89.70 to 92.00 | -1.75% | 0.93 times |
| 14 Thu May 2026 | 91.42 | 90.00 to 91.74 | 1.6% | 0.67 times |
| 13 Wed May 2026 | 89.98 | 89.06 to 90.70 | -0.48% | 1.08 times |
| 12 Tue May 2026 | 90.41 | 90.05 to 92.84 | -2.28% | 1.24 times |
| 11 Mon May 2026 | 92.52 | 92.00 to 93.93 | -2.55% | 2.01 times |
| 08 Fri May 2026 | 94.94 | 94.43 to 95.33 | -0.48% | 0.85 times |
| 07 Thu May 2026 | 95.40 | 92.61 to 96.24 | 2.44% | 4.2 times |
Videos related to: 506235 announcements Alembic Ltd. announcements and dividends declared BSE
Hindi Video Most Important Stock Market Video. No Success Without This Formula
Hindi Video What Is Needed To Succeed In Stock Markets
- BSE Screeners
- BSE Daily Screener
- BSE Weekly Screener
- BSE Monthly Screener
- Support & Resistance
- BSE Shares Near Support
- BSE Shares Near Resistance


